Spatial and temporal control of gene therapy using ionizing radiation
- PMID: 7585181
- DOI: 10.1038/nm0895-786
Spatial and temporal control of gene therapy using ionizing radiation
Abstract
Activation of transcription of the Egr-1 gene by X-rays is regulated by the promoter region of this gene. We linked the radiation-inducible promoter region of the Egr-1 gene to the gene encoding the radiosensitizing and tumoricidal cytokine, tumour necrosis factor-alpha (TNF-alpha) and used a replication-deficient adenovirus to deliver the Egr-TNF construct to human tumours growing in nude mice. Combined treatment with Ad5.Egr-TNF and 5,000 cGy (rad) resulted in increased intratumoral TNF-alpha production and increased tumour control compared with treatment with Ad5.Egr-TNF alone or with radiation alone. The increase in tumour control was achieved without an increase in normal tissue damage when compared to tissue injury from radiation alone. Control of gene transcription by ionizing radiation in vivo represents a novel method of spatial and temporal regulation of gene-based medical treatments.
Similar articles
-
Combined gene therapy and ionizing radiation is a novel approach to treat human esophageal adenocarcinoma.Ann Surg Oncol. 2002 Jun;9(5):500-4. doi: 10.1007/BF02557275. Ann Surg Oncol. 2002. PMID: 12052763
-
Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.Gene Ther. 1998 Mar;5(3):293-300. doi: 10.1038/sj.gt.3300594. Gene Ther. 1998. PMID: 9614548
-
Tumor necrosis factor alpha (TNF-alpha) gene therapy targeted by ionizing radiation selectively damages tumor vasculature.Cancer Res. 1996 Oct 1;56(19):4311-4. Cancer Res. 1996. PMID: 8813113
-
Radiation therapy: activation for gene transcription and the development of genetic radiotherapy-therapeutic strategies in oncology.Cancer Biol Ther. 2003 Jul-Aug;2(4):326-9. doi: 10.4161/cbt.2.4.495. Cancer Biol Ther. 2003. PMID: 14508100 Review.
-
Radiation-inducible gene therapy.C R Acad Sci III. 1999 Feb-Mar;322(2-3):225-8. doi: 10.1016/s0764-4469(99)80047-x. C R Acad Sci III. 1999. PMID: 10196676 Review.
Cited by
-
New paradigms and future challenges in radiation oncology: an update of biological targets and technology.Sci Transl Med. 2013 Feb 20;5(173):173sr2. doi: 10.1126/scitranslmed.3005148. Sci Transl Med. 2013. PMID: 23427246 Free PMC article.
-
Phase I evaluation of TNFerade biologic plus chemoradiotherapy before esophagectomy for locally advanced resectable esophageal cancer.Gastrointest Endosc. 2012 Jun;75(6):1139-46.e2. doi: 10.1016/j.gie.2012.01.042. Epub 2012 Apr 18. Gastrointest Endosc. 2012. PMID: 22520270 Free PMC article. Clinical Trial.
-
STAT1 pathway mediates amplification of metastatic potential and resistance to therapy.PLoS One. 2009 Jun 8;4(6):e5821. doi: 10.1371/journal.pone.0005821. PLoS One. 2009. PMID: 19503789 Free PMC article.
-
Exploiting Radiation Induction of Antigens in Cancer: Targeted Drug Delivery.Int J Mol Sci. 2022 Mar 11;23(6):3041. doi: 10.3390/ijms23063041. Int J Mol Sci. 2022. PMID: 35328459 Free PMC article. Review.
-
Insertion or deletion of the Cheo box modifies radiation inducibility of Clostridium promoters.Appl Environ Microbiol. 2001 Oct;67(10):4464-70. doi: 10.1128/AEM.67.10.4464-4470.2001. Appl Environ Microbiol. 2001. PMID: 11571144 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical